Cali Biosciences

Cali Biosciences is a dynamic international biopharmaceutical company dedicated to the research and development of innovative drugs. With a focus on perioperative medications, including anesthesia, analgesia, anti-inflammatory, and anti-infection treatments, Cali Biosciences is committed to addressing unmet global needs in healthcare. The company operates with an international team of scientific research and management professionals, developing novel drugs based on several patented technology platforms.

Cali Biosciences maintains state-of-the-art laboratories and offices in Shenzhen, China, and San Diego, USA, along with a clinical development center in Shanghai, China. The primary address is 南山区工业五路5号万维大楼 401-403A, 深圳市, 广东省 518067, CN. Additional locations include 浦东新区 祥科路298号佑越国际1座4楼F-space张江中心410-C17, 上海, 201210, CN and 9675 Businesspark Ave, 圣地亚哥, 加利福尼亚州 92131, US. Cali Biosciences is focused on the R&D and production of innovative drugs, registration and application, as well as Sino-US market research, strategic operations, and commercialization.

With a robust product pipeline consisting of several modified new drugs based on the 505(b)(2) regulatory pathways, Cali Biosciences aims to secure approvals from regulatory agencies in China, the US, and the EU. The company’s goal is to deliver innovative drugs to global markets, improving human survival and quality of life. The management team at Cali Biosciences is working diligently to complete further company information. We invite the manager of Cali Biosciences to create a customized and exclusive company showcase and product listing on our platform.